Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine

Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine

The leading malaria vaccine in development is the circumsporozoite (CS) protein-based vaccine, RTS,S, which targets the pre-erythrocytic stage of Plasmodium falciparum infection. It induces modest levels of protective efficacy largely mediated by CS specific antibodies. We aimed to enhance vaccine e...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Gilbert, S, Collins, K, Snaith, R, Cottingham, M, Hill, A
Formáid:	Journal article
Foilsithe / Cruthaithe:	Nature Publishing Group 2017

Míreanna comhchosúla

Inclusion of cGAMP within virus-like particle vaccines enhances their immunogenicity
de réir: Chauveau, L, et al.
Foilsithe / Cruthaithe: (2021)

Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines
de réir: Jerri C. Caldeira, et al.
Foilsithe / Cruthaithe: (2020-04-01)

Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity.
de réir: Jo-Anne Chan, et al.
Foilsithe / Cruthaithe: (2019-01-01)

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.
de réir: Schneider, J, et al.
Foilsithe / Cruthaithe: (1998)

Ultra-low dose immunization and multi-component vaccination strategies enhance protection against malaria in mice
de réir: Katharine A. Collins, et al.
Foilsithe / Cruthaithe: (2021-05-01)

Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models.
de réir: Dégano, P, et al.
Foilsithe / Cruthaithe: (1999)

Protein particle vaccines against malaria.
de réir: Gilbert, S, et al.
Foilsithe / Cruthaithe: (1997)

Virus-like particles as vaccine adjuvants.
de réir: Gilbert, S
Foilsithe / Cruthaithe: (2001)

Virus-like particle vaccines
de réir: Mukhopadhyay, E, et al.
Foilsithe / Cruthaithe: (2022)

Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease
de réir: Bennett J. Davenport, et al.
Foilsithe / Cruthaithe: (2022-05-01)

Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults.
de réir: Moorthy, V, et al.
Foilsithe / Cruthaithe: (2003)

Pigs Immunized with the Virus-like Particle Vaccine Are Protected against the Hepatitis E-3 Virus
de réir: Hyeon-Jeong Go, et al.
Foilsithe / Cruthaithe: (2021-11-01)

Virus-like Particle Vaccines of Infectious Bursal Disease Virus Expressed in <i>Escherichia coli</i> Are Highly Immunogenic and Protect against Virulent Strain
de réir: Pengchao Ji, et al.
Foilsithe / Cruthaithe: (2023-10-01)

Immunization with Virus-Like Particle Vaccine Protects Rabbits against Hepatitis E-3 Virus Infection
de réir: Hyeon-Jeong Go, et al.
Foilsithe / Cruthaithe: (2022-06-01)

Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species
de réir: Dicks, M, et al.
Foilsithe / Cruthaithe: (2011)

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.
de réir: Mcshane, H, et al.
Foilsithe / Cruthaithe: (2001)

Immunogenicity and protective efficacy of a novel bacterium-like particle-based vaccine displaying canine distemper virus antigens in mice and dogs
de réir: Jianzhong Wang, et al.
Foilsithe / Cruthaithe: (2024-04-01)

Intranasal vaccination with murabutide enhances humoral and mucosal immune responses to a virus-like particle vaccine.
de réir: Erin M Jackson, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Complete protective immunity against blood-stage malaria induced by heterologous prime-boost vaccination
de réir: Draper, S, et al.
Foilsithe / Cruthaithe: (2005)

Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines.
de réir: Draper, S, et al.
Foilsithe / Cruthaithe: (2010)

The requirement for potent adjuvants to enhance the immunogenicity and protective efficacy of protein vaccines can be overcome by prior immunization with a recombinant adenovirus.
de réir: de Cassan, S, et al.
Foilsithe / Cruthaithe: (2011)

Virus-like particle (VLP) plus microcrystalline tyrosine (MCT) adjuvants enhance vaccine efficacy improving T and B cell immunogenicity and protection against Plasmodium berghei/vivax
de réir: Cabral-Miranda, G, et al.
Foilsithe / Cruthaithe: (2017)

Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax
de réir: Gustavo Cabral-Miranda, et al.
Foilsithe / Cruthaithe: (2017-05-01)

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes.
de réir: Gilbert, S, et al.
Foilsithe / Cruthaithe: (2002)

A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity.
de réir: Ambühl, P, et al.
Foilsithe / Cruthaithe: (2007)

A Preclinical Immunogenicity Study of the Recombinant Human Papillomavirus Nine-Valent Virus-like Particle Vaccine
de réir: Dan Xu, et al.
Foilsithe / Cruthaithe: (2024-11-01)

Dose immunogenicity study of a plant-produced influenza virus-like particle vaccine in layer hens
de réir: Celia Abolnik, et al.
Foilsithe / Cruthaithe: (2022-06-01)

Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations.
de réir: Gilbert, S, et al.
Foilsithe / Cruthaithe: (1999)

Residual baculovirus in insect cell-derived influenza virus-like particle preparations enhances immunogenicity.
de réir: Irina Margine, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Incorporation of GM-CSF or CD40L Enhances the Immunogenicity of Hantaan Virus-Like Particles
de réir: Lin-Feng Cheng, et al.
Foilsithe / Cruthaithe: (2016-12-01)

Immunogenicity and protective efficacy of human metapneumovirus virus-like particles produced by a recombinant baculovirus in mice
de réir: Fenlian Ma, et al.
Foilsithe / Cruthaithe: (2023-10-01)

Potent Protective Immune Responses to <i>Senecavirus</i> Induced by Virus-Like Particle Vaccine in Pigs
de réir: Suyu Mu, et al.
Foilsithe / Cruthaithe: (2020-09-01)

Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance.
de réir: Moore, A, et al.
Foilsithe / Cruthaithe: (2005)

Immunogenicity of vaccines for malaria-exposed populations
de réir: Bowyer, GSA
Foilsithe / Cruthaithe: (2018)

Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
de réir: Saghi Nooraei, et al.
Foilsithe / Cruthaithe: (2021-02-01)

Mass Production of Virus-Like Particles Using Chloroplast Genetic Engineering for Highly Immunogenic Oral Vaccine Against Fish Disease
de réir: Yoichi Nakahira, et al.
Foilsithe / Cruthaithe: (2021-08-01)

4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaques.
de réir: Spencer, A, et al.
Foilsithe / Cruthaithe: (2014)

Functionalisation of Virus-Like Particles Enhances Antitumour Immune Responses
de réir: Katrin Kramer, et al.
Foilsithe / Cruthaithe: (2019-01-01)

Uncovering the mechanisms of adenovirus vector immunogenicity
de réir: Dicks, M, et al.
Foilsithe / Cruthaithe: (2013)

Heterologous vaccine immunogenicity, efficacy, and immune correlates of protection of a modified-live virus porcine reproductive and respiratory syndrome virus vaccine
de réir: Jessica Proctor, et al.
Foilsithe / Cruthaithe: (2022-09-01)